Histocompatibility antigens and La Crosse encephalitis

Area of Science:

• Immunogenetics
• Neurovirology
• Public Health

Background:

• La Crosse encephalitis is a significant cause of pediatric arboviral encephalitis in the United States.
• The role of host genetic factors in the susceptibility and clinical presentation of La Crosse encephalitis remains largely unexplored.
• Major histocompatibility complex (MHC) antigens are crucial for immune responses and have been implicated in various infectious diseases.

Purpose of the Study:

• To investigate the association between human leukocyte antigen (HLA) antigen profiles and La Crosse encephalitis.
• To determine if specific HLA alleles are linked to susceptibility or specific clinical manifestations, such as seizures, in La Crosse encephalitis patients.

Main Methods:

• Lymphocyte samples were collected from 79 patients diagnosed with La Crosse encephalitis and 69 healthy control subjects.
• Human leukocyte antigen (HLA) typing for HLA-ABC and HLA-DR loci was performed on all participants.
• Statistical analysis was used to compare the frequencies of specific HLA antigens between the patient and control groups.

Main Results:

• The HLA-B49 antigen was found in 11% of La Crosse encephalitis patients but in none of the control subjects (P < .01).
• HLA-DR5 positivity was significantly lower in patients experiencing acute-phase seizures (7%) compared to nonseizure patients (37%) (P < .025).
• These findings indicate a potential association between specific HLA alleles and the immunogenetic profile of La Crosse encephalitis.

Conclusions:

• The study suggests an immunogenetic component influencing susceptibility to La Crosse encephalitis.
• Specific HLA antigen profiles may play a role in the development and clinical course of La Crosse encephalitis, including seizure activity.
• Further research into the immunogenetics of La Crosse encephalitis could inform prevention and treatment strategies.